Current Neuro-Oncology

Volume 22 Number 6
31 March 2020

Home > Publications > Current Neuro-Oncology > Volume 22, Year 2020 > Number 6, 31 March


Bakas S, Shukla G, Akbari H, Erus G, Sotiras A, Rathore S, Sako C, Min Ha S, Rozycki M, Singh A, Shinohara R, Bilello M, Davatzikos C.
Integrative radiomic analysis for pre-surgical prognostic stratification of glioblastoma patients: from advanced to basic MRI protocols.
Proc SPIE Int Soc Opt Eng. 2020 Mar 16, 2020;11315:113151S
. doi: 10.1117/12.2566505. PMID: 33746333. Observational study. ˍ

Nunna RS, Khalid S, Ryoo JS, Mehta AI.
Adult primary high-grade spinal glioma: a nationwide analysis of current trends in treatment and outcomes.
J Neurooncol. 2020 Mar 17, 2020 May;147(3):633-641. doi: 10.1007/s11060-020-03458-z. PMID: 32185646. Observational study. ˍ

Ranjan T, Howard CM, Yu A, Xu L, Aziz K, Jho D, Leonardo J, Hameed MA, Karlovits SM, Wegner RE, Fuhrer R, Lirette ST, Denning KL, Valluri J, Claudio PP.
Cancer Stem Cell Chemotherapeutics Assay for Prospective Treatment of Recurrent Glioblastoma and Progressive Anaplastic Glioma: A Single-Institution Case Series.
Transl Oncol. 2020 Mar 17;13(4):100755. doi: 10.1016/j.tranon.2020.100755. PMID: 32197147. Observational study. ˍ

Brem S, Henderson F.
Commentary: 5-Aminolevulinic Acid and Contrast-Enhanced Ultrasound: The Combination of the 2 Techniques to Optimize the Extent of Resection in Glioblastoma Surgery.
Neurosurgery. 2020 Mar 18, 2020;86(6):E541-E543. doi: 10.1093/neuros/nyaa061. PMID: 32186338. Comment. ˍ
Refers to: Della Pepa GM, et al., 5-Aminolevulinic Acid and Contrast-Enhanced Ultrasound: The Combination of the Two Techniques to Optimize the Extent of Resection in Glioblastoma Surgery.
Neurosurgery. 2020 Mar 18, 2020;86(6):E529-E540. doi: 10.1093/neuros/nyaa037. PMID: 32186345. Observational study. ˍ


Buszek SM, Al Feghali KA, Elhalawani H, Chevli N, Allen PK, Chung C.
Optimal Timing of Radiotherapy Following Gross Total or Subtotal Resection of Glioblastoma: A Real-World Assessment using the National Cancer Database.
Sci Rep. 2020 Mar 18, 2020;10(1):4926. doi: 10.1038/s41598-020-61701-z. PMID: 32188907. Observational study. ˍ

Della Pepa GM, Ius T, La Rocca G, Gaudino S, Isola M, Pignotti F, Rapisarda A, Mazzucchi E, Giordano C, Dragonetti V, Chiesa S, Balducci M, Gessi M, Skrap M, Olivi A, Marchese E, Sabatino G.
5-Aminolevulinic Acid and Contrast-Enhanced Ultrasound: The Combination of the Two Techniques to Optimize the Extent of Resection in Glioblastoma Surgery.
Neurosurgery. 2020 Mar 18, 2020;86(6):E529-E540. doi: 10.1093/neuros/nyaa037. PMID: 32186345. Observational study. ˍ

Zhang Y, Ma JP, Weng JC, Wang L, Wu Z, Li D, Zhang JT.
The clinical, radiological, and immunohistochemical characteristics and outcomes of primary intracranial gliosarcoma: a retrospective single-centre study.
Neurosurg Rev. 2020 Mar 18, 2021;44(2):1003-1015. doi: 10.1007/s10143-020-01285-4. PMID: 32189095. Observational study. ˍ

Metz MC, Molina-Romero M, Lipkova J, Gempt J, Liesche-Starnecker F, Eichinger P, Grundl L, Menze B, Combs SE, Zimmer C, Wiestler B.
Predicting Glioblastoma Recurrence from Preoperative MR Scans Using Fractional-Anisotropy Maps with Free-Water Suppression.
Cancers (Basel). 2020 Mar 19, 2020;12(3):E728. doi: 10.3390/cancers12030728. PMID: 32204544. Observational study. ˍ

Alharbi M, Mobark N, Bashawri Y, Abu Safieh L, Alowayn A, Aljelaify R, AlSaeed M, Almutairi A, Alqubaishi F, AlSolme E, Ahmad M, Al-Banyan A, Alotabi FE, Serrano J, Snuderl M, Al-Rashed M, Abedalthagafi M.
Methylation Profiling of Medulloblastoma in a Clinical Setting Permits Sub-classification and Reveals New Outcome Predictions.
Front Neurol. 2020 Mar 20, 2020;11:167. doi: 10.3389/fneur.2020.00167. PMID: 32265819. Laboratory investigation. ˍ

Marcus AP, Marcus HJ, Camp SJ, Nandi D, Kitchen N, Thorne L.
Improved Prediction of Surgical Resectability in Patients with Glioblastoma using an Artificial Neural Network.
Sci Rep. 2020 Mar 20;10(1):5143. doi: 10.1038/s41598-020-62160-2. PMID: 32198487. Observational study. ˍ

Pasqual E, Castaño-Vinyals G, Thierry-Chef I, Kojimahara N, Sim MR, Kundi M, Krewski D, Momoli F, Lacour B, Remen T, Radon K, Weinmann T, Petridou E, Moschovi M, Dikshit R, Sadetski S, Maule M, Farinotti M, Ha M, 't Mannetje A, Alguacil J, Aragonés N, Vermeulen R, Kromhout H, Cardis E.
Exposure to Medical Radiation during Fetal Life, Childhood and Adolescence and Risk of Brain Tumor in Young Age: Results from The MOBI-Kids Case-Control Study.
Neuroepidemiology. 2020 Mar 20, 2020;54(4):343-355. doi: 10.1159/000506131. PMID: 32200380. Observational study. ˍ

Pratt D, Quezado M, Abdullaev Z, Hawes D, Yang F, Garton HJL, Judkins AR, Mody R, Chinnaiyan A, Aldape K, Koschmann C, Venneti S.
Diffuse intrinsic pontine glioma-like tumor with EZHIP expression and molecular features of PFA ependymoma.
Acta Neuropathol Commun. 2020 Mar 20, 2020;8(1):37. doi: 10.1186/s40478-020-00905-w. PMID: 32197665. Case report. ˍ

Song J, Kadaba P, Kravitz A, Hormigo A, Friedman J, Belani P, Hadjipanayis C, Ellingson BM, Nael K.
Multiparametric MRI for early identification of therapeutic response in recurrent glioblastoma treated with immune checkpoint inhibitors.
Neuro Oncol. 2020 Mar 20, 2020;22(11):1658-1666. doi: 10.1093/neuonc/noaa066. PMID: 32193547. Observational study. ˍ

Scartoni D, Amelio D, Palumbo P, Giacomelli I, Amichetti M.
Proton therapy re-irradiation preserves health-related quality of life in large recurrent glioblastoma.
J Cancer Res Clin Oncol. 2020 Mar 21, 2020;146(6):1615-1622. doi: 10.1007/s00432-020-03187-w. PMID: 32200460. Observational study. ˍ

Dong J, Li L, Liang S, Zhao S, Zhang B, Meng Y, Zhang Y, Li S.
Differentiation Between Ependymoma and Medulloblastoma in Children with Radiomics Approach.
Acad Radiol. 2020 Mar 26, 2021;28(3):318-327
. doi: 10.1016/j.acra.2020.02.012. PMID: 32222329. Observational study. ˍ

Federici L, Capelle L, Annereau M, Bielle F, Willekens C, Dehais C, Laigle-Donadey F, Hoang-Xuan K, Delattre JY, Idbaih A, Lemare F, de Botton S, Sanson M, Touat M.
5-Azacitidine in Patients with IDH1/2-mutant Recurrent Glioma.
Neuro Oncol. 2020 Mar 26, 2020;22(8):1226-1228. doi: 10.1093/neuonc/noaa074. PMID: 32215616. Expanded access study. ˍ

Peng J, Zhou H, Tang O, Chang K, Wang P, Zeng X, Shen Q, Wu J, Xiao Y, Patel SH, Hu C, Jin K, Xiao B, Boxerman J, Gao X, Wen PY, Bai HX, Huang RY, Yang L.
Evaluation of RAPNO criteria in medulloblastoma and other leptomeningeal seeding tumors using MRI and clinical data.
Neuro Oncol. 2020 Mar 26, 2020;22(10):1536-1544. doi: 10.1093/neuonc/noaa072. PMID: 32215549. Observational study. ˍ

Saito R, Kanamori M, Sonoda Y, Yamashita Y, Nagamatsu K, Murata T, Mugikura S, Kumabe T, Wembacher-Schröder E, Thomson R, Tominaga T.
Phase I trial of convection-enhanced delivery of nimustine hydrochloride (ACNU) for brainstem recurrent glioma.
Neurooncol Adv. 2020 Mar 26, 2020;2(1):vdaa033. doi: 10.1093/noajnl/vdaa033. PMID: 32642691. Interventional study. ˍ

Valiyaveettil D, Malik M, Akram KS, Ahmed SF, Joseph DM.
Prospective study to assess the survival outcomes of planned irradiation of ipsilateral subventricular and periventricular zones in glioblastoma.
Ecancermedicalscience. 2020 Mar 26, 2020;14:1021. doi: 10.3332/ecancer.2020.1021. PMID: 32256704. Observational study. ˍ

Eichberg DG, Di L, Morell AA, Shah AH, Semonche AM, Chin CN, Bhatia RG, Jamshidi AM, Luther EM, Komotar RJ, Ivan ME.
Incidence of high grade gliomas presenting as radiographically non-enhancing lesions: experience in 111 surgically treated non-enhancing gliomas with tissue diagnosis.
J Neurooncol. 2020 Mar 27, 2020;147(3):671-679. doi: 10.1007/s11060-020-03474-z. PMID: 32221785. Observational study. ˍ

Massey SC, White H, Whitmire P, Doyle T, Johnston SK, Singleton KW, Jackson PR, Hawkins-Daarud A, Bendok BR, Porter AB, Vora S, Sarkaria JN, Hu LS, Mrugala MM, Swanson KR.
Image-based metric of invasiveness predicts response to adjuvant temozolomide for primary glioblastoma.
PLoS One. 2020 Mar 27, 2020;15(3):e0230492. doi: 10.1371/journal.pone.0230492. PMID: 32218600. Observational study. ˍ

Giussani C, Guida L, Biassoni V, Schiavello E, Carrabba G, Trezza A, Sganzerla E, Massimino M.
Observational study of the clinical and radiological features of 94 consecutive DIPGs patients to investigate the factors determining the development of hydrocephalus and its impact on clinical status and survival.
Childs Nerv Syst. 2020 Mar 28, 2020;36(11):2701-2705. doi: 10.1007/s00381-020-04589-4. PMID: 32222799. Observational study. ˍ

Haldbo-Classen L, Amidi A, Lukacova S, Wu LM, Oettingen GV, Lassen-Ramshad Y, Zachariae R, Kallehauge JF, Høyer M.
Cognitive impairment following radiation to hippocampus and other brain structures in adults with primary brain tumours.
Radiother Oncol. 2020 Mar 28, 2020;148:1-7. doi: 10.1016/j.radonc.2020.03.023. PMID: 32298906. Observational study. ˍ

Nada A, Abdelrahman A, Cunningham C, Cousins J.
Radio-pathological review of a metastatic renal cell carcinoma within a meningioma: A case report of collision tumor.
Radiol Case Rep. 2020 Mar 28, 2020;15(5):637‐640. doi: 10.1016/j.radcr.2020.02.031. PMID: 32256926. Case report. ˍ

Chai RC, Zhang YW, Liu YQ, Chang YZ, Pang B, Jiang T, Jia WQ, Wang YZ.
The molecular characteristics of spinal cord gliomas with or without H3 K27M mutation.
Acta Neuropathol Commun. 2020 Mar 30, 2020;8(1):40. doi: 10.1186/s40478-020-00913-w. PMID: 32228694. Laboratory investigation. ˍ

Goda JS, Dutta D, Krishna U, Goswami S, Gupta T, Kothavade V, Kannan S, Maitre M, Bano N, Jalali R.
Hippocampal radiotherapy dose-constraints for predicting long-term neurocognitive outcomes: Mature data from a prospective trial in young patients with brain tumors.
Neuro Oncol. 2020 Mar 30, 2020;22(11):1677-1685. doi: 10.1093/neuonc/noaa076. PMID: 32227185. Observational study. ˍ

de Oliveira Nascimento J, Haro LCA, Sá RDS, Storch RE.
Metachronic Breast and Cerebellar Neoplasm in a Young Patient.
Rev Bras Ginecol Obstet. 2020 Mar 30, 2020;42(2):114-119. doi: 10.1055/s-0040-1701456 PMID: 32227327. Case report. ˍ


Mantilla EC Jr, Abramowitz J, Dan TU, Pan E.
Prolonged Steroid Dependence in Adult Patients With Glioma.
Anticancer Res. 2020 Mar 31, 2020;40(4):2059‐2064. doi: 10.21873/anticanres.14163. PMID: 32234897. Observational study. ˍ

Zhou X, Niu X, Mao Q, Liu Y.
Clinical Significance of Various Classification Standards of Age Groups in Predicting Survival of Patients with Glioblastoma.
Med Sci Monit. 2020 Mar 31, 2020;26:e920627. doi: 10.12659/MSM.920627. PMID: 32471970. Observational study. ˍ